Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Mitochondria in hematopoiesis and hematological diseases

Oncogene volume 25, pages 4757–4767 (2006)Cite this article

Abstract

Mitochondria are involved in hematopoietic cell homeostasis through multiple ways such as oxidative phosphorylation, various metabolic processes and the release of cytochrome c in the cytosol to trigger caspase activation and cell death. In erythroid cells, the mitochondrial steps in heme synthesis, iron (Fe) metabolism and Fe-sulfur (Fe-S) cluster biogenesis are of particular importance. Mutations in the specific δ-aminolevulinic acid synthase (ALAS) 2 isoform that catalyses the first and rate-limiting step in heme synthesis pathway in the mitochondrial matrix, lead to ineffective erythropoiesis that characterizes X-linked sideroblastic anemia (XLSA), the most common inherited sideroblastic anemia. Mutations in the adenosine triphosphate-binding cassette protein ABCB7, identified in XLSA with ataxia (XLSA-A), disrupt the maturation of cytosolic (Fe-S) clusters, leading to mitochondrial Fe accumulation. In addition, large deletions in mitochondrial DNA, whose integrity depends on a specific DNA polymerase, are the hallmark of Pearson's syndrome, a rare congenital disorder with sideroblastic anemia. In acquired myelodysplastic syndromes at early stage, exacerbation of physiological pathways involving caspases and the mitochondria in erythroid differentiation leads to abnormal activation of a mitochondria-mediated apoptotic cell death pathway. In contrast, oncogenesis-associated changes at the mitochondrial level can alter the apoptotic response of transformed hematopoietic cells to chemotherapeutic agents. Recent findings in mitochondria metabolism and functions open new perspectives in treating hematopoietic cell diseases, for example various compounds currently developed to trigger tumor cell death by directly targeting the mitochondria could prove efficient as either cytotoxic drugs or chemosensitizing agents in treating hematological malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Aerbajinai W, Giattina M, Lee YT, Raffeld M, Miller JL . (2003). Blood 102: 712–717.

  • Astner I, Schulze JO, van den Heuvel J, Jahn D, Schubert WD, Heinz DW . (2005). EMBO J 24: 3166–3177.

  • Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Bueler H . (2000). Hum Mol Genet 9: 803–811.

  • Banker DE, Cooper JJ, Fennell DA, Willman CL, Appelbaum FR, Cotter FE . (2002). Leuk Res 26: 91–106.

  • Becattini B, Sareth S, Zhai D, Crowell KJ, Leone M, Reed JC, Pellecchia M . (2004). Chem Biol 11: 1107–1117.

  • Becker EM, Greer JM, Ponka P, Richardson DR . (2002). Blood 99: 3813–3822.

  • Belzacq AS, Jacotot E, Vieira HL, Mistro D, Granville DJ, Xie Z et al. (2001). Cancer Res 61: 1260–1264.

  • Benesch M, Platzbecker U, Ward J, Deeg HJ, Leisenring W . (2003). Leukemia 17: 2460–2466.

  • Berger G, Hunault-Berger M, Rachieru P, Fontenay-Roupie M, Baranger L, Ifrah N et al. (2001). Hematol J 2: 87–96.

  • Bombrun A, Gerber P, Casi G, Terradillos O, Antonsson B, Halazy S . (2003). J Med Chem 46: 4365–4368.

  • Bouchier-Hayes L, Lartigue L, Newmeyer DD . (2005). J Clin Invest 115: 2640–2647.

  • Bouscary D, Chen YL, Guesnu M, Picard F, Viguier F, Lacombe C et al. (2000). Exp Hematol 28: 784–791.

  • Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J et al. (1997). Leukemia 11: 839–845.

  • Bowen D, Peddie C . (2002). Br J Haematol 118: 345–346; author reply 346.

  • Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F et al. (2006). Blood 107: 1156–1165.

  • Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C et al. (1993). Blood 81: 3091–3096.

  • Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F et al. (1996). Science 271: 1423–1427.

  • Carlile GW, Smith DH, Wiedmann M . (2004). Blood 103: 4310–4316.

  • Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E et al. (2004). Blood 103: 3355–3361.

  • Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E et al. (2003). Blood 101: 1996–2000.

  • Chandra J, Mansson E, Gogvadze V, Kaufmann SH, Albertioni F, Orrenius S . (2002). Blood 99: 655–663.

  • Chauhan D, Li G, Podar K, Hideshima T, Shringarpure R, Catley L et al. (2004). Blood 103: 3158–3166.

  • Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A et al. (1997). Science 278: 1966–1968.

  • Chinnery PF, Samuels DC, Elson J, Turnbull DM . (2002). Lancet 360: 1323–1325.

  • Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV . (2004). Proc Natl Acad Sci USA 101: 4578–4583.

  • Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, Gisselbrecht S et al. (2002). Blood 99: 1594–1601.

  • Claessens YE, Park S, Dubart-Kupperschmitt A, Mariot V, Garrido C, Chretien S et al. (2005). Blood 105: 4035–4042.

  • Claessens YE, Park S, dubrez-Daloz L, Garrido C, Lacombe C, Drefrus F et al. (2003). Blood 102: 144a. (S1).

  • Cotter PD, May A, Li L, Al-Sabah AI, Fitzsimons EJ, Cazzola M et al. (1999). Blood 93: 1757–1769.

  • Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK . (1994). N Engl J Med 330: 675–679.

  • Craven SE, French D, Ye W, de Sauvage F, Rosenthal A . (2005). Blood 105: 3528–3534.

  • De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O et al. (2002). Blood 100: 1310–1317.

  • De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E et al. (1999). Blood 93: 796–803.

  • Decaudin D, Castedo M, Nemati F, Beurdeley-Thomas A, De Pinieux G, Caron A et al. (2002). Cancer Res 62: 1388–1393.

  • del Rio G, Castro-Obregon S, Rao R, Ellerby HM, Bredesen DE . (2001). FEBS Lett 494: 213–219.

  • Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL et al. (2002). Blood 100: 194–199.

  • Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD et al. (1999). Nat Med 5: 1032–1038.

  • Fadeel B, Hassan Z, Hellstrom-Lindberg E, Henter JI, Orrenius S, Zhivotovsky B . (1999). Leukemia 13: 719–728.

  • Fellous R, Coulaud D, el Abed I, Roques BP, Le Pecq JB, Delain E et al. (1988). Cancer Res 48: 6542–6549.

  • Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari Jr AW et al. (2005). Cancer Res 65: 6294–6304.

  • Fleming MD, Campagna DR, Haslett JN, Trenor III CC, Andrews NC . (2001). Genes Dev 15: 652–657.

  • Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML et al. (2004). Blood 104: 2565–2573.

  • Furuyama K, Fujita H, Nagai T, Yomogida K, Munakata H, Kondo M et al. (1997). Blood 90: 822–830.

  • Furuyama K, Sassa S . (2000). J Clin Invest 105: 757–764.

  • Gattermann N . (2000). Leuk Res 24: 141–151.

  • Gattermann N, Retzlaff S, Wang YL, Berneburg M, Heinisch J, Wlaschek M et al. (1996). Br J Haematol 93: 845–855.

  • Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, Aul C et al. (1997). Blood 90: 4961–4972.

  • Gattermann N, Wulfert M, Hofhaus G . (2002). Br J Haematol 119: 1139; author reply 1139–1140.

  • Genini D, Adachi S, Chao Q, Rose DW, Carrera CJ, Cottam HB et al. (2000). Blood 96: 3537–3543.

  • Gersuk GM, Lee JW, Beckham CA, Anderson J, Deeg HJ . (1996). Blood 88: 1122–1123.

  • Gojo I, Zhang B, Fenton RG . (2002). Clin Cancer Res 8: 3527–3538.

  • Gomez-Bougie P, Bataille R, Amiot M . (2004). Eur J Immunol 34: 3156–3164.

  • Gomez-Bougie P, Bataille R, Amiot M . (2005a). Eur J Immunol 35: 971–976.

  • Gomez-Bougie P, Oliver L, Le Gouill S, Bataille R, Amiot M . (2005b). Oncogene 24: 8076–8079.

  • Grasso JA, Myers TJ, Hines JD, Sullivan AL . (1980). Br J Haematol 46: 57–72.

  • Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ . (1999). Blood 94: 87–96.

  • Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C et al. (1999). Leukemia 13: 44–53.

  • Hafid-Medheb K, Augery-Bourget Y, Minatchy MN, Hanania N, Robert-Lezenes J . (2003). Blood 101: 2575–2583.

  • Harigae H, Nakajima O, Suwabe N, Yokoyama H, Furuyama K, Sasaki T et al. (2003). Blood 101: 1188–1193.

  • He L, Luo L, Proctor SJ, Middleton PG, Blakely EL, Taylor RW et al. (2003). Leukemia 17: 2487–2491.

  • Hellstrom-Lindberg E, Schmidt-Mende J, Forsblom AM, Christensson B, Fadeel B, Zhivotovsky B . (2001). Br J Haematol 112: 714–726.

  • Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A . (1993). Proc Natl Acad Sci USA 90: 8479–8483.

  • Hermine O, Haioun C, Lepage E, d’Agay MF, Briere J, Lavignac C et al. (1996). Blood 87: 265–272.

  • Hishita T, Tada-Oikawa S, Tohyama K, Miura Y, Nishihara T, Tohyama Y et al. (2001). Cancer Res 61: 2878–2884.

  • Houwerzijl EJ, Blom NR, van der Want JJ, Louwes H, Esselink MT, Smit JW et al. (2005). Blood 105: 3472–3479.

  • Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N et al. (2000). J Exp Med 191: 33–46.

  • Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van Elsas A, Muller M et al. (1998). Nat Med 4: 232–234.

  • Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskova M et al. (1998). Br J Haematol 100: 304–309.

  • Jourdan M, De Vos J, Mechti N, Klein B . (2000). Cell Death Differ 7: 1244–1252.

  • Jourdan M, Veyrune JL, Vos JD, Redal N, Couderc G, Klein B . (2003). Oncogene 22: 2950–2959.

  • Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. (2004). J Immunol 173: 2976–2984.

  • Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, Gore SD et al. (1998). Blood 91: 991–1000.

  • Kerbauy DM, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ . (2005). Blood 106: 3917–3925.

  • Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R . (1998). Leukemia 12: 486–492.

  • Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H et al. (2002). J Exp Med 196: 1347–1353.

  • Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S . (1997). Science 277: 559–562.

  • Kroemer G, de The H . (1999). J Natl Cancer Inst 91: 743–745.

  • Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al. (2005). Science 309: 481–484.

  • Lacour S, Micheau O, Hammann A, Drouineaud V, Tschopp J, Solary E et al. (2003). Oncogene 22: 1807–1816.

  • Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA et al. (1999). Exp Cell Res 249: 413–421.

  • Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C . (2005). Oncogene 24: 5137–5148.

  • Le Gouill S, Podar K, Amiot M, Hideshima T, Chauhan D, Ishitsuka K et al. (2004). Blood 104: 2886–2892.

  • Letai A . (2005). J Clin Invest 115: 2648–2655.

  • Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ . (2004). Cancer Cell 6: 241–249.

  • Lill R, Kispal G . (2000). Trends Biochem Sci 25: 352–356.

  • Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA et al. (2000). Mol Cell 6: 1389–1399.

  • Logette E, Le Jossic-Corcos C, Masson D, Solier S, Sequeira-Legrand A, Dugail I et al. (2005). Mol Cell Biol 25: 9621–9631.

  • Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Mereau-Richard C, Costantini P et al. (1999). Cancer Res 59: 6257–6266.

  • Marczin N, El-Habashi N, Hoare GS, Bundy RE, Yacoub M . (2003). Arch Biochem Biophys 420: 222–236.

  • Matthes TW, Kindler V, Leuba F, French LE, Chapuis B, Beris P et al. (2002). Leukemia 16: 1319–1323.

  • Matthes TW, Meyer G, Samii K, Beris P . (2000). Br J Haematol 111: 843–852.

  • Meijerink JP, Mensink EJ, Wang K, Sedlak TW, Sloetjes AW, de Witte T et al. (1998). Blood 91: 2991–2997.

  • Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT . (1999). J Biol Chem 274: 7987–7992.

  • Michels J, Johnson PW, Packham G . (2005). Int J Biochem Cell Biol 37: 267–271.

  • Moreaux J, Legouffe E, Jourdan E, Quittet P, Reme T, Lugagne C et al. (2004). Blood 103: 3148–3157.

  • Moshynska O, Sankaran K, Pahwa P, Saxena A . (2004). J Natl Cancer Inst 96: 673–682.

  • Motoyama N, Kimura T, Takahashi T, Watanabe T, Nakano T . (1999). J Exp Med 189: 1691–1698.

  • Mufti GJ . (2004). Best Pract Res Clin Haematol 17: 543–557.

  • Nakajima O, Takahashi S, Harigae H, Furuyama K, Hayashi N, Sassa S et al. (1999). EMBO J 18: 6282–6289.

  • Napier I, Ponka P, Richardson DR . (2005). Blood 105: 1867–1874.

  • Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH et al. (2005). Blood 105: 3255–3262.

  • Nie G, Sheftel AD, Kim SF, Ponka P . (2005). Blood 105: 2161–2167.

  • Ogasawara Y, Nakayama K, Tarnowka M, McCoy Jr JP, Kajigaya S, Levin BC et al. (2005). Blood 106: 3271–3284.

  • Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. (2005). Nature 435: 677–681.

  • Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ . (2003). Nature 426: 671–676.

  • Oren Z, Ramesh J, Avrahami D, Suryaprakash N, Shai Y, Jelinek R . (2002). Eur J Biochem 269: 3869–3880.

  • Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon MF et al. (2003). J Neurooncol 63: 81–86.

  • Pandolfo M . (2003). Semin Pediatr Neurol 10: 163–172.

  • Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A . (2000). Blood 96: 3932–3938.

  • Pasanen AV, Vuopio P, Borgstrom GH, Tenhunen R . (1981). Scand J Haematol 27: 35–44.

  • Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT et al. (1979). J Pediatr 95: 976–984.

  • Ponka P . (1999). Am J Med Sci 318: 241–256.

  • Puthier D, Bataille R, Amiot M . (1999). Eur J Immunol 29: 3945–3950.

  • Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, Yasui H et al. (2005). Blood 106: 1042–1047.

  • Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R et al. (1995). Blood 86: 268–276.

  • Reddy PL, Shetty VT, Dutt D, York A, Dar S, Mundle SD et al. (2002). Br J Haematol 116: 564–575.

  • Richardson DR, Ponka P, Vyoral D . (1996). Blood 87: 3477–3488.

  • Rotig A, Cormier V, Koll F, Mize CE, Saudubray JM, Veerman A et al. (1991). Genomics 10: 502–504.

  • Rudin CM, Kozloff M, Hoffman PC, Edelman MJ, Karnauskas R, Tomek R et al. (2004). J Clin Oncol 22: 1110–1117.

  • Sandrelli A, De Fabritiis P, Capua A, Mandelli F, Zupi G, Leonetti C . (1992). Eur J Cancer 28A: 1633–1636.

  • Sawada M, Hayes P, Matsuyama S . (2003). Nat Cell Biol 5: 352–357.

  • Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB, Cohen C . (2002). Cytometry 50: 203–209.

  • Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. (2002). Cell 109: 335–346.

  • Schmitt CA, Rosenthal CT, Lowe SW . (2000). Nat Med 6: 1029–1035.

  • Serkova NJ, Christians U, Benet LZ . (2004). Mol Interv 4: 97–107.

  • Shetty V, Hussaini S, Alvi S, Joshi L, Shaher A, Dangerfield B et al. (2002). Br J Haematol 116: 817–825.

  • Shimada Y, Okuno S, Kawai A, Shinomiya H, Saito A, Suzuki M et al. (1998). J Hum Genet 43: 115–122.

  • Shin MG, Kajigaya S, Levin BC, Young NS . (2003). Blood 101: 3118–3125.

  • Shin MG, Kajigaya S, McCoy Jr JP, Levin BC, Young NS . (2004). Blood 103: 553–561.

  • Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al. (2002). Nat Med 8: 68–74.

  • Shirihai OS, Gregory T, Yu C, Orkin SH, Weiss MJ . (2000). EMBO J 19: 2492–2502.

  • Singh KK, Russell J, Sigala B, Zhang Y, Williams J, Keshav KF . (1999). Oncogene 18: 6641–6646.

  • Sordet O, Rebe C, Leroy I, Bruey JM, Garrido C, Miguet C et al. (2001). Blood 97: 3931–3940.

  • Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, Vainchenker W et al. (2002). Blood 100: 4446–4453.

  • Takada S, Shirakata Y, Kaneniwa N, Koike K . (1999). Oncogene 18: 6965–6973.

  • Taketani S, Kakimoto K, Ueta H, Masaki R, Furukawa T . (2003). Blood 101: 3274–3280.

  • Tehranchi R, Fadeel B, Forsblom AM, Christensson B, Samuelsson J, Zhivotovsky B et al. (2003). Blood 101: 1080–1086.

  • Tehranchi R, Fadeel B, Schmidt-Mende J, Forsblom AM, Emanuelsson E, Jadersten M et al. (2005). Clin Cancer Res 11: 6291–6299.

  • Testa U . (2004). Leukemia 18: 1176–1199.

  • Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE et al. (2004). Nature 429: 417–423.

  • Tura S, Cavo M, Gobbi M, Franchi P . (1984). Oncology 41: Suppl 1, 90–93.

  • Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL et al. (1998). Immunity 9: 267–276.

  • Waldmeier PC, Feldtrauer JJ, Qian T, Lemasters JJ . (2002). Mol Pharmacol 62: 22–29.

  • Walker A, Taylor ST, Hickman JA, Dive C . (1997). Cancer Res 57: 1939–1945.

  • Walsh M, Lutz RJ, Cotter TG, O’Connor R . (2002). Blood 99: 3439–3448.

  • Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG . (2001). Proc Natl Acad Sci USA 98: 4038–4043.

  • Wang JL, Zhang ZJ, Choksi S, Shan S, Lu Z, Croce CM et al. (2000). Cancer Res 60: 1498–1502.

  • Watabe M, Machida K, Osada H . (2000). Cancer Res 60: 5214–5222.

  • Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F et al. (2000). J Clin Oncol 18: 1812–1823.

  • Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001). Science 292: 727–730.

  • Weisberg EL, Koya K, Modica-Napolitano J, Li Y, Chen LB . (1996). Cancer Res 56: 551–555.

  • Weisleder N, Taffet GE, Capetanaki Y . (2004). Proc Natl Acad Sci USA 101: 769–774.

  • Woo M, Hakem R, Furlonger C, Hakem A, Duncan GS, Sasaki T et al. (2003). Nat Immunol 4: 1016–1022.

  • Yakes FM, Van Houten B . (1997). Proc Natl Acad Sci USA 94: 514–519.

  • Yamamoto K, Abe S, Nakagawa Y, Suzuki K, Hasegawa M, Inoue M et al. (2004). Leuk Res 28: 1203–1211.

  • Yamamoto M, Nakajima O . (2000). Int J Hematol 72: 157–164.

  • Zamzami N, Kroemer G . (2001). Nat Rev Mol Cell Biol 2: 67–71.

  • Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. (2001). J Exp Med 193: 247–254.

  • Zhang B, Potyagaylo V, Fenton RG . (2003). Oncogene 22: 1848–1859.

  • Zhivotovsky B, Orrenius S . (2005). Biochem Biophys Res Commun 331: 859–867.

  • Zhong Q, Gao W, Du F, Wang X . (2005). Cell 121: 1085–1095.

  • Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P . (2003). Blood 101: 4098–4104.

  • Zinkel SS, Ong CC, Ferguson DO, Iwasaki H, Akashi K, Bronson RT et al. (2003). Genes Dev 17: 229–239.

Download references

Acknowledgements

ES and SC are supported by a label and a grant from the Ligue Nationale Contre le Cancer, respectively. MF is supported by a grant from Inca and the Délégation Régionale de la Recherche Clinique de l’Assistance Publique des Hôpitaux de Paris. EG is supported by the Fondation de France. MA is supported by the Ligue Nationale Contre le Cancer.

Author information

Authors and Affiliations

  1. Department of Hematology, Inserm U567, Institut Cochin, Paris, Cedex, France

    M Fontenay & E Gyan

  2. Inserm U601, Biology Institute, Nantes, Cedex, France

    S Cathelin & E Solary

  3. Inserm U517, Faculty of Medicine, Dijon, France

    M Amiot

Authors
  1. M Fontenay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Cathelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Amiot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Gyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Solary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Solary.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fontenay, M., Cathelin, S., Amiot, M. et al. Mitochondria in hematopoiesis and hematological diseases. Oncogene 25, 4757–4767 (2006). https://doi.org/10.1038/sj.onc.1209606

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209606

Keywords

This article is cited by

Search

Advanced search

Quick links